Contemporary OB/GYN week in review: mifepristone, cervical cancer, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OB/GYN week in review: mifepristone, cervical cancer, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, June 10 - Friday, June 14, 2024), and click each link to read and watch anything you may have missed.
1.) Supreme Court retains nationwide access to mifepristone
In a unanimous ruling, the Supreme Court rejected a challenge by antiabortion doctors, maintaining nationwide access to mifepristone for medication abortions and reversing a lower court's decision to restrict the pill's availability.
Click here for the full article.
2.) Guidelines released to boost cervical cancer screening in high-income countries
The ACCESS Consensus Group's new guidelines aim to enhance cervical cancer screening and reduce mortality rates in high-income countries, emphasizing the urgent need for increased participation and innovative approaches such as self-sampling.
Click here for the full article.
3.) Sex-based disparities for hospital quality linked to increased female mortality rate
A recent study reveals that female Medicare beneficiaries face a significant increase in mortality disparity compared to male beneficiaries, particularly at lower-quality hospitals, underscoring the need for equitable access to high-quality care.
Click here for the full article.
4.) Rising prevalence of hypertensive disorders of pregnancy reported
A recent study reveals a significant increase in hypertensive disorders among pregnant individuals in the United States from 2010 to 2021, highlighting the need for focused public health measures to mitigate modifiable risk factors.
Click here for the full article.
5.) Chronic kidney disease linked to tooth loss in postmenopausal women
A new study recently published in Menopause, the journal of The Menopause Society, suggests a significant link between chronic kidney disease (CKD) and tooth loss, particularly in postmenopausal women.
S4E3: Myfembree for moderate-to-severe endometriosis pain: Potential for adolescents
March 2nd 2022In this episode of Pap Talk, Contemporary OB/GYN® Associate Editor Lindsey Carr sat down with Jessica Shim, MD, an attending at in the Division of Gynecology, Department of Surgery, Boston Children’s Hospital; Harvard Medical School Boston, Massachusetts, to discuss Myfembree (relugolix, estradiol, and norethindrone acetate tablets; Myovant Sciences, Pfizer) and its possible approval in May 2022.
Listen
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
